Kenvue, known for its slogan "A new view of care 🤍", has established itself as the world’s largest pure-play consumer health company by revenue. Founded in 2023, this United States-based company stands on a rich heritage spanning over a century, coupled with a forward-looking approach driven by scientific innovation. Its impressive portfolio boasts iconic brands such as Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®, Neutrogena®, Tylenol®, and Zyrtec®.
Kenvue leverages a digital-first mindset and focuses on innovation rooted in deep human insights. Its products are highly trusted by consumers and health care professionals alike, with the aim of enhancing everyday health and wellness.
The company received a significant undisclosed investment of $48.70B on 03 November 2025 from Kimberly-Clark, underscoring substantial investor confidence in its growth trajectory and market leadership in consumer health.